Kodiak CFO exercises options for 28,614 shares

Kodiak Sciences Inc. Chief Financial Officer John A. Borgeson exercised stock options to acquire 28,614 shares of common stock at an exercise price of $1.04 per share.

Accepted by SEC EDGAR 04/16/2026 - 05:00 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Kodiak Sciences Inc. Chief Financial Officer John A. Borgeson exercised stock options to acquire 28,614 shares of common stock at an exercise price of $1.04 per share. Following the transaction, he directly owns 211,930 common shares and holds options for 30,000 additional shares. The options exercised were already fully vested, indicating this was a routine compensation-related exercise rather than an open-market purchase or sale.

Insider Trade Summary

28,614 shares exercised/converted

Exercise 2 txns

Insider BORGESON JOHN A.

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy)	28,614	$0.00	$0.00
Exercise	Common Stock	28,614	$1.04	$30K

Holdings After Transaction: Stock Option (Right to Buy) — 30,000 contracts (Direct); Common Stock — 211,930 shares (Direct)

Footnotes (1)

1. F1. The shares subject to this option are fully vested.

Key Figures

Options exercised: 28,614 shares Exercise price: $1.04 per share Common shares held after: 211,930 shares +2 more

5 metrics

Options exercised 28,614 shares Stock option exercise on 2026-04-15

Exercise price $1.04 per share Strike price for stock options exercised

Common shares held after 211,930 shares Direct Kodiak Sciences common stock ownership after exercise

Options remaining after 30,000 shares Stock options position following the reported transaction

Option expiration date 2026-06-22 Expiration date for the exercised option grant

Key Terms

Stock Option (Right to Buy), derivative security, fully vested, transaction code M, +1 more

5 terms

Stock Option (Right to Buy) financial

"security_title: "Stock Option (Right to Buy)""

derivative security financial

"transaction_code_description: "Exercise or conversion of derivative security""

A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

fully vested financial

"footnote: "The shares subject to this option are fully vested.""

transaction code M financial

"transaction_code: "M" for option exercise"

direct ownership financial

"ownership_type: "direct", ownership_code: "D""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Kodiak Sciences (KOD) CFO John Borgeson report in this Form 4?

Kodiak Sciences CFO John A. Borgeson reported exercising stock options to acquire 28,614 shares of common stock. The options carried a strike price of $1.04 per share and were fully vested, reflecting routine compensation-related activity rather than open-market trading.

How many Kodiak Sciences (KOD) shares does the CFO hold after the option exercise?

After exercising options, CFO John A. Borgeson directly holds 211,930 shares of Kodiak Sciences common stock. This total reflects the addition of 28,614 shares acquired through the option exercise disclosed in the Form 4 filing for the reported transaction date.

What was the exercise price of the Kodiak Sciences (KOD) options used by the CFO?

The options exercised by Kodiak Sciences CFO John A. Borgeson had an exercise price of $1.04 per share. He exercised these options to acquire 28,614 shares of common stock, converting a derivative position into an equivalent number of directly held shares.

Did the Kodiak Sciences (KOD) CFO sell any shares in this Form 4 transaction?

The Form 4 shows no share sales by the Kodiak Sciences CFO. John A. Borgeson exercised options coded as transaction type “M,” acquiring 28,614 common shares and increasing his direct holdings to 211,930 shares without any reported open-market dispositions.

Are the options exercised by the Kodiak Sciences (KOD) CFO fully vested?

Yes, a footnote states that the shares subject to this option are fully vested. This means the CFO’s exercise of 28,614 option shares at $1.04 per share reflects previously earned compensation rather than new or contingent awards subject to additional vesting conditions.

What option position remains for the Kodiak Sciences (KOD) CFO after this exercise?

Following the transaction, the Form 4 shows 30,000 stock options remaining for the Kodiak Sciences CFO. These are recorded as “total shares following transaction” for the derivative security, separate from his 211,930 directly held common shares after the option exercise.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BORGESON JOHN A.

(Last) (First) (Middle)

1250 PAGE MILL ROAD

(Street)

PALO ALTO CALIFORNIA 94304

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Kodiak Sciences Inc. [ KOD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/15/2026		M		28,614	A	$1.04	211,930	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$1.04	04/15/2026		M			28,614	(1)	06/22/2026	Common Stock	28,614	$0	30,000	D

Explanation of Responses:

1. The shares subject to this option are fully vested.

	/s/ David Peinsipp, Attorney-in-Fact for John A. Borgeson	04/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)